Jill Hagenkord

Chief Medical Officer


Optum Genomics

Jill is a Board-certified pathologist with subspecialty boards in molecular genetic pathology and an additional fellowship in pathology-oncology informatics.

Jill is Active in Association for Molecular Pathology (AMP), American College of Medical Genetic and Genomics (ACMG), College of American Pathologists (CAP), and National Academy of Medicine’s Roundtable for Genomics and Precision Medicine. She is Former CMO of Invitae, 23andMe, and Color. Currently the CMO of Optum Genomics

Jill’s interests are coding, coverage, reimbursement of molecular diagnostics, product development, and commercialization of health tech products, consumer engagement in health, population health.